Orlistat: From antiobesity drug to anticancer agent in her-2/neu (erbB-2)-overexpressing gastrointestinal tumors?

Javier A. Menendez, Luciano Vellon, Ruth Lupu

Research output: Contribution to journal › Comment/debate › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Orlistat: From antiobesity drug to anticancer agent in her-2/neu (erbB-2)-overexpressing gastrointestinal tumors?'. Together they form a unique fingerprint.